Navigation Links
AMRI Appoints Anthony J. Maddaluna to Board of Directors

ALBANY, N.Y., Feb. 4, 2016 /PRNewswire/ -- AMRI (NASDAQ:  AMRI) today announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016. In addition, the Company announced that Mr. Gabe Leung, a director and member of the audit committee since 2010, has retired from the AMRI Board of Directors in order to devote further time and attention to his other business ventures. 

"Tony is a terrific addition to our Board of Directors, and we are extremely pleased to bring his extensive and valuable global pharmaceutical expertise to AMRI," said William S. Marth, President and CEO. "We believe Tony's insights and counsel will be very beneficial for AMRI as we look to further expand our differentiated service offerings and serve as a strategic outsourcing resource for our customers.

I would like to thank Gabe for his dedicated service to AMRI over the last 5 years. His expertise in the pharmaceutical industry has been a tremendous asset to us and I appreciate his enthusiasm and counsel as we've transformed AMRI into an integrated contract research, development and manufacturing company. We wish him all the best in his future endeavors."

Tony's career with Pfizer spans more than 40 years. He joined Pfizer in 1975 in St. Louis, Missouri, serving in the Minerals, Pigments and Metals (MPM) division in several positions, including Production Supervisor. From 1978 to 1983, he held various engineering positions in the Adams, Massachusetts, MPM division and subsequently worked in the Pharmaceutical division as Manager, Technical Training. In 1985, Tony relocated to Terre Haute, Indiana, where he held various positions before becoming Plant Manager. In 1994, he moved to Pfizer's Barceloneta, Puerto Rico plant as General Manager. He was named Vice President/Team Leader, Europe in 1998 and also had responsibility for Global Logistics, Global Operations Team and Strategic Planning during a portion of this time. He was named Vice President, Strategy & Supply Network Transformation in 2008, and Senior Vice President in 2009. Tony was named to his current position at Pfizer in 2011. Before joining Pfizer, Tony worked at the U.S. Environmental Protection Agency and at Johnson & Johnson as an engineer. Tony represents Pfizer on the National Association of Manufacturers (NAM) and is a member of the NAM Executive Committee. Tony holds a B.S. in Chemical Engineering from Northeastern University and an M.B.A. in Management and Organization Development from Southern Illinois University.

"I am honored to be appointed to AMRI's Board of Directors," said Anthony J. Maddaluna. "AMRI has established itself as an innovative force and a rapidly growing CRO/CDMO within the pharmaceutical outsourcing services industry, and I'm eager to contribute to the Company's continued growth." 

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, steroids, hormones, cytotoxic compounds and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations.


Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
2. Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
3. Smart Insurance Company Appoints John Gardynik CEO
4. Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Companys Drug Development Pipeline
5. Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer
6. Sinovac Appoints New Chief Financial Officer
7. Prime Therapeutics appoints Scott Fries as senior vice president of government programs
8. Agendia Appoints Peter W. Schineller as Chief Commercial Officer
9. Dynatronics Appoints R. Scott Ward, PT PhD to its Board of Directors
10. PAREXEL International Appoints Ingo Bank As Senior Vice President And Chief Financial Officer
11. PDL BioPharma Appoints Glenn Reicin as Senior Advisor
Post Your Comments:
(Date:2/23/2020)... (PRWEB) , ... February 23, ... ... Recovery has received a three-year accreditation by CARF International, the Commission on ... health and human services whose mission is to promote quality, value, and ...
(Date:2/21/2020)... ... February 21, 2020 , ... Special Learning, Inc. is the leading global provider ... about changing the lives of people with autism and other special needs. ... find employment opportunities. Special Learning will be providing some of the key components ...
(Date:2/20/2020)... ... February 20, 2020 , ... NeoTract, a wholly owned subsidiary ... urology, today announced that Jayant Uberoi, MD, Chesapeake Urology in Baltimore MD, has ... Uberoi has achieved a high level of training and experience with the UroLift® ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... TMQuotes ... release with next generation API integration functionality which enables agents to take more ... in 2017, TMQuotes was the first white label software-as-a-service (SaaS) to give insurance ...
(Date:2/19/2020)... ... February 19, 2020 , ... MedTech IGNITE ... to Apply to Participate in 2020 Cohort , The Massachusetts Medical Device Industry ... is now accepting applications from startup founders and CEOs to participate in the ...
(Date:2/19/2020)... ... 2020 , ... SafiraMD Medical Aesthetics & Wellness Center is ... most popular non-invasive fat reduction treatment. Their CoolEvent will be held on March ... Alpharetta, Georgia. The CoolEvent will feature live demonstrations, exclusive discounts, giveaways and much ...
(Date:2/15/2020)... ... , ... It all started back in 2010, when Jennifer Martinez (Founder) was ... she was on to something special. The Heartsters have now become a circle ... a health condition or illness, a disability or just having a bad day. ...
(Date:2/13/2020)... ... February 13, 2020 , ... The Root Cause Coalition, representing ... equity for all Americans will unveil its new Status of Health Equity Report ... National Press Club. , The event will feature a presentation and discussion of ...
Breaking Medicine News(10 mins):